|

Azadirachta indica A. Juss. (Meliaceae)
Synonyms
Melia azadirachta L., M. indica (A. Juss.) Brand., M. indica Brand.
Local names
Abodua, aforo-oyinbo, anwe egyane, arista, azad dirakht, azadarakht, azedarach,
bead tree, bevinama, bevu, bewina mara, bodetso, bo-nim, cape lilac, chajara
hourra, chichaâne arbi, China berry, China tree, cót anh, darbejiya,
dogo yaro, dogo’n yaro, dogonyaro, dogoyaro, dongo yaro, dua gyane, gori,
gringging, holy tree, igi-oba, imba, Indian lilac, Indian lilac tree, Indian
neem tree, Indian sadao, Intaran, isa-bevu, jaroud, kahibevu, kingtsho, kiswahhili,
kohhomba, kohumba, koummar, kuman masar, kuman nasara, kwinin, labkh, lilac
de perse, lilas des indes, liliti, limb, limba, limbado, limado, linigbe, mahanim,
mahanimba, mahnimu, mak tong, margosa, margosa tree, margose, marrar, mimba,
mindi, miro tahiti, mwarobaini, neeb, neem, neem sikha, nim, nim tree, nimba,
nimbatikta, nimgach, nivaquine, ogwu akom, oilevevu, ouchi, Persian lilac, phãk
kã dão, picumarda, sa-dao, sa-dao baan, sadao India, sdau, salien,
sandan, sandannoki, sãu dâu, senjed talhk, shajarat el horrah,
shereesh, tâak, tâakhak, touchenboku, vembu, vemmu, vepa, veppam,
veppu, white cedar, xoan dào, zanzalakht, zaytoon
Description
A straight-boled deciduous tree 6–25 m high. Bark dark-brown, externally
fissured, with a buff inner surface, fi brous fracture. Leaves alternately arranged,
pinnately compound, up to 40 cm long, composed of 8–
18 short-petiolate narrow-ovate, pointed, curved toothed leafl ets, 3–10
cm long and 1–4 cm wide arranged in alternate pairs. Infl orescences axillary
panicles; fl owers numerous, white, pedicillate, about 1.0 cm wide. Fruits yellowish
drupes, oblong, about 1.5 cm long, containing thin pulp surrounding a single
seed. When bruised, leaves and twigs emit an onion-like odour
Plant material used
dried leaves, Other plant parts are also used, but not included here: flowers,
seeds, stem bark, oil
Chemical assays
High-performance liquid chromatography methods are available for the quantitative
determination of oxidized tetranortriterpenes
Major chemical constituents
The major characteristic constituents are oxidized tetranortriterpenes including
azadirachtin (azadirachtin A), 3-tigloylazadirachtol (azadirachtin B), 1-tigloyl-3-acetyl-11-hydroxy-meliacarpin
(azadirachtin D), 11-demethoxycarbonyl azadirachtin (azadirachtin H), 1-tigloyl-3-
acetyl-11-hydroxy-11-demethoxycarbonyl meliacarpin (azadirachtin I), azadiriadione,
azadirachtanin, epoxyazadiradione, nimbin, deacetylnimbin, salannin, azadirachtolide,
isoazadirolide, margosinolide, nimbandiol, nimbinene, nimbolin A, nimbocinone,
nimbocinolide, nimbolide, nimocin, nimocinol and related derivatives
Medicinal uses
Uses supported by clinical data
External applications for treatment of ringworm. However, data from controlled
clinical trials are lacking.
Uses described in pharmacopoeias and well established
documents
Treatment of worm and lice infections, jaundice, external ulcers, cardiovascular
disease, diabetes, gingivitis, malaria, rheumatism and skin disorders. External
applications for treatment of septic wounds and boils
Uses described in traditional medicine
Treatment of allergic skin reactions, asthma, bruises, colic, conjunctivitis,
dysentery, dysmenorrhoea, delirium in fever, gout, headache, itching due to
varicella, jaundice, kidney stones, leprosy, leukorrhoea, psoriasis, scabies,
smallpox, sprains and muscular pain, syphilis, yellow fever, warts and wounds.
Also used as an antivenin, contraceptive, emmenagogue, tonic, stomatic and vermicide
Proven pharmacological activity
Animal studies
Anxiolytic and analgesic, Antiandrogenic, Antihepatotoxic, Anti-inflammatory,
Antihyperglycaemic, Antimalarial, Antimicrobial and antiviral, Antioxidant,
Antiulcer, Immunomodulator
Human studies
Ringworm
Adverse reactions
A case of ventricular fibrillation and cardiac arrest due to neem leaf poisoning
has been reported. Contact dermatitis has also been reported
Contraindications
Owing to potential genotoxic effects, the leaves should not be administered
during pregnancy or nursing, or to children under the age of 12 years.
Warnings
No information available.
Precautions
Drug interactions
Administration of Folium Azadirachti may reduce blood glucose levels and should
therefore be used with caution in insulin-dependent diabetic patients or patients
taking oral antihyperglycaemic drugs.
Carcinogenesis, mutagenesis, impairment of fertility
A petroleum ether extract of the leaves was not mutagenic in the Salmonella/microsome
assay at concentrations of 0.1 ml/plate using S. typhimurium strains TA98, TA100,
TA1535 and TA1537. Intragastric administration of 5.0 mg/10 g bw, 10.0 mg/10
g bw or 20.0 mg/10 g bw of an ethanol extract of the leaves per day for 7 days
to mice signifi cantly (P < 0.05) increased the incidence of structural and
mitotic disruptive changes in metaphase chromosomes of bone marrow cells on
days 8, 15 and 35. Intragastric administration of 100.0 mg/kg bw of an ethanol
extract of the leaves per day for 21 days had no effect on spermatogenesis in
male rats, and no effect on implantation in female animals mated with treated
males
Pregnancy: teratogenic effects
Intragastric administration of 200.0 mg/kg bw of an acetone or 50% ethanol extract
of the leaves to pregnant rats on days 1–7 of pregnancy did not produce
any teratogenic or embryotoxic effects.
Nursing mothers
See Contraindications.
Paediatric use
See Contraindications.
Other precautions
No information available on general precautions or on precautions concerning
drug and laboratory test reactions; or non-teratogenic effects in pregnancy.
Dosage forms
Dried leaves for infusions and decoctions, and extracts and tinctures. Store
leaves in a cool, dry place
Posology
(Unless otherwise indicated)
Infusion (1:20): 15–30 ml. Tincture (1:5): 4–8 ml. External applications:
70% ethanol extract of the leaves diluted to 40%, apply twice daily
Plant material used
fixed oil
Chemical assays
A high-performance liquid chromatography procedure is available for the quantitative
determination of oxidized tetranortriterpenes
Major chemical constituents
The major constituents are oxidized tetranortriterpenes including azadirachtin
(azadirachtin A), azadiriadione, epoxyazadiradione, azadirone, nimbidin, nimbin,
deacetylnimbin, salannin, gedunin, mahmoodin, 17- hydroxydiradione and related
derivatives
Medicinal uses
Uses supported by clinical data
As a contraceptive for intravaginal use, as a mosquito repellent, and for treatment
of vaginal infections. However, further controlled clinical trials are needed
before the oil can be recommended for general use.
Uses described in pharmacopoeias and well established
documents
Treatment of gastric ulcers, cardiovascular disease, malaria, rheumatism and
skin disorders. External applications for treatment of septic wounds, ulcers
and boils.
Uses described in traditional medicine
Treatment of allergic skin reactions, asthma, bruises, colic, conjunctivitis,
dysmenorrhoea, fever, gout, headache, itching due to varicella, kidney stones,
leukorrhoea, psoriasis, scabies, sprains and muscular pain, and wounds. As an
emmenagogue, tonic, stomatic and vermicide.
Proven pharmacological activity
Animal studies
Antifertility, Antihyperglycaemic, Anti-inflammatory, Antimicrobial and antiviral,
Antiulcer, Estrogenic, Immunomodulator
Human studies
Contraceptive, Antibacterial, Insect repellent, Treatment of skin disorders
Adverse reactions
A 60-year-old male was admitted to hospital with neurological and psychotic
symptoms following ingestion of 60.0 ml of Oleum Azadirachti. However, correlation
of the adverse effects with ingestion of the oil was not definitely proven
Contraindications
Oral administration of Oleum Azadirachti is contraindicated during pregnancy,
nursing and in children under the age of 12 years.
Warnings
A number of cases of toxicity, including toxic encephalopathy, poisoning and
Reye-like syndrome, following ingestion of excessive doses of Oleum Azadirachti
have been reported.
Precautions
Drug interactions
Administration of the oil may reduce blood glucose levels. It should therefore
be used with caution in insulin-dependent diabetic patients or patients taking
oral antihyperglycaemic drugs.
Carcinogenesis, mutagenesis, impairment of fertility
An acetone extract of the oil was inactive at concentrations of up to 200.0
mg/plate in the Salmonella/microsome assay using Salmonella typhimurium strains
TA98 and TA100. In the same test, the oil (concentration not specifi ed) was
not mutagenic using Salmonella typhimurium strains TA98 and TA100, with or without
metabolic activation. The oil has demonstrated antifertility effects in numerous
animal and human studies
Pregnancy: teratogenic effects
The oil had embryotoxic effects after vaginal administration to pregnant rats
at a dose of 0.25 ml/animal. Embryotoxic effects were also reported following
intragastric administration of 4.0 ml/kg bw of the oil to pregnant rats on days
6–8 of pregnancy.
Pregnancy: non-teratogenic effects
See Contraindications.
Nursing mothers
See Contraindications.
Paediatric use
See Contraindications.
Other precautions
No information available on general precautions or on precautions concerning
drug and laboratory test interactions.
Dosage forms
Oil. Store in a tightly sealed container away from heat and light.
Posology
(Unless otherwise indicated)
Dose: 1.0–5.0 ml of oil for intravaginal applications
|